Evidence map›Paper›PMID 38006316›Full record

ReviewPathogens and global health2024

Raghad H F Bashabsheh, O'la Al-Fawares, Iyad Natsheh, Roba Bdeir, Rozan O Al-Khreshieh, Hasan H F Bashabsheh

Abstract readReview
In one paragraph

Review in Pathogens and global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Pacin, a novel bacteriocin fromMicrobiology spectrum · 2026
    Article
  11. Article
  12. Occurrence of Presumptive Methicillin-ResistantFoods (Basel, Switzerland) · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. TiONanomaterials (Basel, Switzerland) · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raghad H F BashabshehDepartment of Medical Laboratory Analysis, Faculty of Science, Al-Balqa Applied University, Al-salt, Jordan.
O'la Al-FawaresDepartment of Medical Laboratory Analysis, Faculty of Science, Al-Balqa Applied University, Al-salt, Jordan.ORCID 0000-0002-5735-4382
Iyad NatshehDepartment of Allied Medical Sciences, Zarqa College, Al-Balqa Applied University, Zarqa, Jordan.
Roba BdeirDepartment of Allied Health Sciences, Faculty of Nursing, Al-Balqa Applied University, Al-salt, Jordan.
Rozan O Al-KhreshiehDepartment of Medical Laboratory Analysis, Faculty of Science, Al-Balqa Applied University, Al-salt, Jordan.
Hasan H F BashabshehFaculty of Medicine, University of Jordan, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsHumansNanotechnologyVirulence FactorsAnti-Bacterial AgentsVirulence Factorsantibiotic resistanceMDRmesoporous silica nanoparticlesnanotechnologyStaphylococcus aureus

Identifiers

PMID38006316
PMCPMC11221481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.